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Abstract
Obesity and depression are major public health concerns, and there is increasing evidence that they share etiological
mechanisms. CREB-regulated transcription coactivator 1 (CRTC1) participates in neurobiological pathways involved in
both mood and energy balance regulation. Crtc1−/− mice rapidly develop a depressive-like and obese phenotype in
early adulthood, and are therefore a relevant animal model to explore possible common mechanisms underlying
mood disorders and obesity. Here, the obese phenotype of male and female Crtc1−/− mice was further characterized
by investigating CRTC1’s role in the homeostatic and hedonic regulation of food intake, as well as its inﬂuence on daily
locomotor activity. Crtc1−/− mice showed a strong gender difference in the homeostatic regulation of energy balance.
Mutant males were hyperphagic and rapidly developed obesity on normal chow diet, whereas Crtc1−/− females
exhibited mild late-onset obesity without hyperphagia. Overeating of mutant males was accompanied by alterations
in the expression of several orexigenic and anorexigenic hypothalamic genes, thus conﬁrming a key role of CRTC1 in
the central regulation of food intake. No alteration in preference and conditioned response for saccharine was
observed in Crtc1−/− mice, suggesting that mutant males’ hyperphagia was not due to an altered hedonic regulation
of food intake. Intriguingly, mutant males exhibited a hyperphagic behavior only during the resting (diurnal) phase of
the light cycle. This abnormal feeding behavior was associated with a higher diurnal locomotor activity indicating that
the lack of CRTC1 may affect circadian rhythmicity. Collectively, these ﬁndings highlight the male-speciﬁc involvement
of CRTC1 in the central control of energy balance and circadian locomotor activity.
Introduction
Obesity, resulting from an impairment of energy bal-
ance, represents a main public health concern because of
its comorbidity with diabetes, cardiovascular diseases,
cancer, and psychiatric disorders1. Clinical studies report
high prevalence of obesity in patients suffering of chronic
mental illnesses, and among depressive subjects, those
affected by atypical depression have the strongest odd to
develop obesity2. If poor nutrition, lack of exercise, and
psychiatric medication can explain, at least in part, why
this psychiatric population develops obesity, growing
evidence supports the hypothesis that the association of
obesity and depression may originate from shared biolo-
gical pathways3–5. Hence, in order to improve psychiatric
outcomes, a better understanding of the neurobiological
adaptations shared by these two pathologies is of the
highest importance.
CREB-regulated transcription coactivator 1 (CRTC1)
has recently been involved in mood regulation and energy
balance6–10. This transcription coactivator, together with
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CRTC2 and CRTC3, constitutes a family of proteins that
can detect cellular activation and stimulate CREB-
dependent gene expression, independently of CREB
phosphorylation11–13. CRTCs can sense many external
inputs, such as hormones and neurotransmitters, by
detecting cytoplasmic increase of calcium and cAMP
levels. Upon cellular activation, they become depho-
sphorylated and translocate to the nucleus where they
bind to CREB and activate the transcription of several
tissue-speciﬁc CREB-regulated genes. Despite their dif-
ferent expression throughout the body, all the three
CRTC members are involved in energy metabolism.
CRTC3 is essentially expressed in the adipose tissue
where it facilitates fat deposition14, whereas CRTC2 has
been found to regulate gluconeogenesis and insulin sen-
sitivity in the liver and the pancreas, respectively13,15–17.
More recently, CRTC2 has also been detected in the
brain, and in particular in the hypothalamus, where it is
able to link glucose sensing with gene regulation18.
Among the CRTC family members, CRTC1 is the most
abundant in the brain, in particular in the prefrontal
cortex, the hippocampus, the amygdala, and the hypo-
thalamus19–21. Inside the hypothalamus, a key region for
regulating energy balance, CRTC1 is present in the arc-
uate nucleus (ARC), in the ventromedial, and in the
paraventricular hypothalamus21.
Recent evidence collected in Crtc1−/− mice has estab-
lished that not only the lack of CRTC1 induces hyper-
phagic obesity6,7, but it also triggers a depressive-like
phenotype, which suggests that CRTC1 plays a role in
mood disorder etiology and antidepressant response8–10.
In agreement with these animal studies, two human
investigations have highlighted an association of CRTC1
polymorphisms with body mass index and fat mass, and
have suggested that CRTC1 is involved in the high pre-
valence of overweight and obesity observed in psychiatric
patients and in subjects from the general population with
major depressive disorder22,23. Altogether, these ﬁndings
suggest that CRTC1 is a transcriptional coactivator reci-
procally involved in the bidirectional relation between
obesity and depression.
In this study, we further investigated the consequences
of the lack of CRTC1 on the energy balance of Crtc1−/−
male and female mice, with the aim of better deﬁning
CRTC1-regulated molecular pathways involved in obesity,
and possibly in mood disorders as well. Alterations in
energy intake were assessed using three different
approaches: (I) monitoring food consumption and body
weight gain, (II) evaluating the expression of multiple
genes in the ARC of the hypothalamus and (III) deter-
mining the integrity of the hedonic regulation of food
intake by testing the preference and the conditioned
response for saccharine. Moreover, the inﬂuence of
CRTC1 on energy expenditure was assessed through the
measure of the spontaneous and voluntary locomotor
activity. Overall, our results conﬁrm that CRTC1 is cri-
tical for the maintenance of energy balance and show, for
the ﬁrst time, the presence of a clear sexual dimorphism
in the obesity of Crtc1−/− mice, because males develop a
more severe obesity than females, and are more active and




Crtc1−/− mice and Crtc1+/+ wild-type (WT) littermates
were obtained and genotyped as previously described7,8.
Mice were housed in a temperature and humidity-
controlled environment, and received water and stan-
dard rodent chow ad libitum under a 12-h dark–light
cycle, unless otherwise speciﬁed. All behavioral experi-
ments were carried out in the dark phase of the light cycle.
Body weight measurements and behavioral assessments of
the mice were not randomized nor blinded to the inves-
tigator. The procedures were performed in conformity
with the Swiss National Institutional Guidelines on Ani-
mal Experimentation and approved by the Cantonal
Veterinary Ofﬁce.
Body weight and food intake measurements
Six-week-old males and females were single-housed,
and their body weight and food intake measured weekly.
Males were divided in two groups; the ﬁrst was monitored
until 8 weeks of age and the second until 36 weeks.
Assessment of food intake and body weight of females was
protracted until 52 weeks of age. Food consumption
during the dark and light phase of the cycle was measured
when males and females were 30 weeks old. The devel-
opment of obesity in mutant females was also studied in
an additional group of 6-week-old mice fed ad libitum
with a high fat diet (HFD 2127—KLIBA NAFAG: carbo-
hydrates 41.1%, proteins 23.9%, fats 35%, 5.68 Kcal/g)
during 50 days.
Gene expression analysis
After body weight measurements, mice were killed and
fresh brains were rapidly sliced into 1 mm-thick coronal
sections in a mouse brain stainless steel matrix. The slice
containing the hypothalamus was used to dissect the ARC
by a micro-punch technique (0.98 mm diameter micro-
punch, Stoelting). ARC RNA was extracted with an
RNeasy Plus Minikit (Qiagen, Valencia, CA, USA) and
converted in cDNA by reverse transcription reaction
using TaqMan Reverse Transcriptase Reagents (Applied
Biosystem). Real-time PCR ampliﬁcation was performed
with an ABIPRISM 7500 cycler and SYBER green PCR
Master Mix (Applied Biosystem) using speciﬁc sets of
primers (Mycrosynth AG). Forward and reverse primers
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for the tested genes are the following: β-actin= forward:
5′-GCTTCTTTGCAGCTCCTTCGT-3′, reverse: 5′-ATA
TCGTCATCCATGGCGAAC-3′; AgRP= forward: 5′-CG
GAGGTGCTAGATCCACAGA-3′, reverse: 5′-AGGACT
CGTGCAGCCTTACAC-3′; Cart= forward: 5′-TTCCTG
CAATTCTTTCCTCTTGA-3′, reverse: 5′-GGGAATAT
GGGAACCGAAGGT-3′; Fto= forward: 5′-GGACATC
GAGACACCAGGAT-3′, reverse: 5′-AGGTGCCTGTT-
GAGCACTCT-3′; Glp1r= forward: 5′-ACTTTCTTTCT
CCGCCTTGGT-3′, reverse: 5′-TTCCTGGTGCAGTG-
CAAGTG-3′; LepRb= forward: 5′-GCATGCAGAATCA
GTGATATTTGG-3′, reverse: 5′-CAAGCTGTATCGA-
CACTGATTTCTTC-3′; Npy= forward: 5′-CAGAAA
ACGCCCCCAGAAC-3′, reverse: 5′-CGGGAGAACAAG
TTTCATTTCC-3′; Npy-rY1= forward: 5′-CAAGATA-
TACATTCGCTTGA-3′, reverse: 5′-AGATTGTGGT
TGCAGG-3′; Nor1= forward: 5′-TGGCTCGACTC-
CATTAAAGAC-3′, reverse: 5′-TGCATAGCTCCTCCA
CTCTCT-3′. All samples were analyzed in triplicates.
Relative gene expression was measured with the com-
parative ΔΔCt method24 and normalized with β-actin
transcript levels.
Preference and conditioned response for saccharine
Two-bottle choice test
The preference for saccharine was assessed in Crtc1−/−
and WT mice at 16 weeks of age. Individually housed,
mice had simultaneously free access to two drinking
bottles, one containing tap water and the other 0.2%
saccharine solution. The position of the two bottles in the
cage was interchanged every day. Water and saccharine
consumption was measured daily, along 4 days. Sacchar-
ine preference was calculated as preference ratio= (sac-
charine consumption/total liquid consumption)× 100.
Saccharine operant conditioning
Saccharine self-administration was measured in 8-week-
old mice using eight operant chambers (Med Associated
Inc., St. Albans, VT, USA). Mice were trained to self-
administer saccharine 0.2% liquid reward on a ﬁxed ratio
1, time out 3 s (FR1 TO3) schedule of reinforcement in
the presence of an olfactory cue (apple aroma, Givaudan,
Dübendorf, Switzerland) during 30-min daily sessions. A
single nose entry in the active nosepoke activated a liquid
dipper equipped with a 0.01 ml cup and a light cue located
inside the nosepoke. The liquid reward remained available
for 3 s once access to the liquid dipper had been detected
with head entry detectors. Supplementary entries in the
active nosepoke in the absence of head entry detection
above the liquid dipper and entries in the inactive nose-
poke were recorded but had no further consequence.
During the early phase of acquisition, mice were restricted
to the 85% of their daily food consumption. Once fed ad
libitum, mice were trained until stable levels of intake
(≤25% variation of the mean responses for three con-
secutive sessions). To reach this stability criterion of the
acquisition phase, 18 and 13 daily sessions were required
for males and females, respectively. Afterwards, mice
underwent an extinction phase, which lasted 7 and 8 daily
sessions for males and females, respectively, until com-
pletion of the extinction criterion (<30% of the mean
responses obtained during the 3 days achieving the sta-
bilization criterion across 3 consecutive extinction ses-
sions). The day after the last extinction session, mice were
tested for reinstatement of their nosepoking activities
upon presentation of the olfactory and light cues, and the
numbers of entries in the active and inactive nosepokes
were recorded during 30-min sessions while no liquid
reward was delivered. The number of nosepokes was used
to compare Crtc1−/− and WT mice along the entire
procedure.
Measures of locomotor activity
Spontaneous locomotor activity
Spontaneous activity was recorded in standard condi-
tions (food and water ad lib., L:D of 12:12) with a home-
made apparatus (“NEPAAL”25). This device consists of 12
transparent Plexiglas home cages (30× 50× 40 cm) with
sawdust on the ﬂoor and equipped with a passive infrared
movement detector on the top, a food dispenser and a
bottle of water. Eight-week-old mice were individually
placed in the activity cages and habituated 1 week to the
novel environment before starting recording. Activity was
measured by 15min bins over 7 days and was expressed in
arbitrary units.
Activity in running wheel
Voluntary wheel running was monitored in standard
cages equipped with a stainless steel wheel. Each wheel
measured 23 cm of diameter and had a running lane width
of 7.5 cm (2B Biological Instruments, Varese, Italy). Ani-
mals of 8 weeks of age were individually housed in run-
ning wheel cages and acclimated for 7 days before starting
measurements. Water and food were provided ad libitum.
Running activity (number of wheel revolutions/h) was
recorded continuously for 1 week. For each mouse, the
activity in the dark and light phase of the cycle was
measured as the average of the last 3 days of the test, in
which mice performance was stable.
Statistical analyses
All data reported in the text and ﬁgures are means ± s.e.
m. The number of independent samples of each group is
indicated in the ﬁgure legend. The non-homogenous
number of animals tested in each group is either due to
breeding difﬁculties (small number of WT and Crtc1−/−
mice per litter and limited breeding colony size), to
technical problems during the gene expression analyses,
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or to the exclusion of samples according to a predeﬁned
criterion (scores that are more than 2 standard deviations
above or below the mean). Sample sizes were determined
based on power analysis and common practice in beha-
vioral experiments (~12 animals per group). Before per-
forming statistical comparisons, the normality of data
distribution was veriﬁed with Shapiro–Wilk test. Since
normality of saccharine operant conditioning and spon-
taneous activity were not fulﬁlled, raw data underwent
logarithmic transformation. Basal body weight, gene
expression, saccharine preference, total spontaneous
activity, and total food intake over 24 h were compared
with Student’s t test for independent samples, after eva-
luation of homoscedasticity with Levene’s test. Statistical
analysis of body weight gain, cumulative food intake,
saccharine operant conditioning, spontaneous activity,
and food consumption in the dark and light phases, was
done using a repeated measure two-way ANOVA fol-
lowed by Bonferroni post hoc test for multiple compar-
isons, when appropriate. Sphericity assumption, for
repeated measures, was veriﬁed with Mauchly’s test and
degrees of freedom eventually corrected by
Greenhouse–Geisser ε value. Running activity in dark and
light phase was analyzed with Mann–Whitney U test for
non-parametric independent samples. Statistical power of all
analysis was between 0.8 and 1.0. Level of signiﬁcance was set
at P≤ 0.05. All statistical analyses were performed with IBM
SPSS Statistic 23.0 software (IBM, Armonk, NY, USA).
Results
Crtc1−/− male mice are hyperphagic and develop obesity
To characterize the obesity of Crtc1−/− mice, we
monitored food intake and body weight until 36 weeks of
age in males and 52 weeks in females. Measures of food
consumption revealed that starting from 8 weeks of age
Crtc1−/− males were hyperphagic and ate signiﬁcantly
more than controls (Fig. 1a). Unlike males, females did
not exhibit any overeating behavior (Fig. 1d).
No signiﬁcant difference was found in body weight
between young Crtc1−/− and WT mice. Indeed, at
6 weeks of age males (Crtc1−/−= 22.10± 0.32, WT=
23.47± 0.41) and females (Crtc1−/−= 18.58± 0.46, WT
= 18.55± 0.79) of both genotypes showed similar weight
(Fig. 1b, e). However, Crtc1−/− males compared to
females, exhibited a stronger body weight gain with aging.
According with their early overeating, Crtc1−/− males
gained quickly more weight than controls (Fig. 1c).
Measures of body weight gain revealed that Crtc1−/−
males were overweight from the 8th week of age (Bon-
ferroni post hoc, P= 0.0019).
In contrast to males, Crtc1−/− females, which did not
show overeating, had a slower and more moderate body
weight increase (Fig. 1f), as attested by repeated measures
two-way ANOVA (genotype: F(1,24)= 10.527, P= 0.034;
weeks: F(3.185,76.443)= 263.167, P< 0.001; genotype×
weeks: F(3.185,76.443)= 0.508; P= 0.689), even though the
Bonferroni post hoc test did not show any signiﬁcant
comparison. The elevated number of multiple compar-
isons affected this post hoc test, and therefore it did not
reveal speciﬁcally at which weeks of age Crtc1−/− females
had a signiﬁcant higher body weight gain, as compared
with WT females. Nevertheless, the signiﬁcant effect of
the genotype revealed by the ANOVA showed that
mutant females globally gained more weight than WT
females. An independent weight gain comparison of the
52-week-old Crtc1−/− and WT females actually con-
ﬁrmed this difference (Crtc1−/−= 22.4± 1.9 versus WT
= 16.7± 1.4, Student’s t test, P= 0.023). Further corro-
borating the absence of hyperphagia and early-onset
obesity in mutant females, 6-week-old mice were fed ad
libitum with HFD for 50 days (Supplementary Fig. S1).
Crtc1−/− and WT females consumed equivalent amount
of HFD (repeated measures two-way ANOVA: genotype:
F(1,12)= 1.637, P= 0.225; days: F(1.03,12.881)= 833.32, P<
0.001; genotype× days: F(1.03,12.881)= 1.336; P= 0.278)
and gained similar body weight (repeated measures two-
way ANOVA: genotype: F(1,12)= 0.62, P= 0.808; days:
F(1.233,14793)= 37.464, P< 0.001; genotype× days:
F(1.233,14793)= 0.421; P= 0.568). Taken together, these
data show that the lack of CRTC1 seriously increases
feeding behavior and body weight gain of male mice,
whereas it has only a weak impact on energy balance of
mutant females.
Orexigenic and anorexigenic gene expression is altered in
the ARC of Crtc1−/− males
Given the presence of CRTC1 in the ARC and the
pivotal role played by this structure in the homeostatic
regulation of food intake, we investigated whether Crtc1−/−
males’ hyperphagia could be linked to an imbalance in the
expression of anorexigenic and orexigenic genes. We
compared ARC gene expression in 8-week-old and 36-
week-old Crtc1−/− and WT males (Table 1 and Fig. 2a–h),
as well as the relative expression of four anorexigenic
genes (LepRb, Cart, Nor1, and Glp-r1), three orexigenic
genes (AgRP, Npy, and Npy-y1) and the fat-mass-related
and obesity-related gene (Fto). In the ARC of 36-week-old
Crtc1−/− males, we found signiﬁcant downregulation of
LepRb, Cart, Nor1, and Fto, increased expression of Npy
and no change in the expression of AgRP, Npy-y1, and
Glp-r1. At 8 weeks of age, the lack of Crtc1 induced sig-
niﬁcant reduction of Nor1 and Fto and upregulation of
AgRP, as compared with WT males. On the other hand,
we did not observe, at this age, any difference in the
relative level of LepRb, Cart, Npy, Npy-y1, and Glp-r1.
Consistent with the absence of hyperphagia, 52-week-old
mutant females did not exhibit any change of Cart, AgRP,
Npy, and Glp-r1 expression, but only increased levels of
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Fig. 1 Effect of CRTC1 deﬁciency on food intake and body weight in male and female mice. a–c Cumulative food intake and body weight gain in
Crtc1−/− (n = 12) and wild-type (WT) males (n = 14). a Crtc1−/− males eat signiﬁcantly more than WT (repeated measures two-way ANOVA: genotype:
F(1,24) = 20.737, P < 0.001; weeks: F(1.65,39.66) = 34,572.49, P < 0.001; genotype × weeks: F(1.65,39.66) = 3.309, P = 0.055) and their overeating is already
present at 7 weeks of age, as shown in the inserted graph b Comparison of basal body weight in 6-week-old WT and Crtc1−/− males shows no
signiﬁcant difference (P = 0.129). c Crtc1−/− males gain more weight than WT (repeated measures two-way ANOVA: genotype: F(1, 24) = 53.537; P <
0.001; weeks: F(3.001,72.031) = 513.07; P < 0.001; genotype × weeks: F(3.001,72.031) = 513.073; P < 0.001). d–f Cumulative food intake and body weight gain
in Crtc1−/− (n = 11) and WT females (n = 15). d No hyperphagia was observed in Crtc1−/− females until 52 weeks of age (repeated measures two-way
ANOVA: genotype: F(1,24) = 0.176, P = 0.678; weeks: F(1.041,24.982) = 1944.94, P < 0.001; genotype × weeks: F(1.041,24.982) = 0.43, P = 0.526). e Comparison of
basal body weight in 6 weeks old WT and Crtc1−/− females. Basal body weight was identical in both genotypes (P = 0.969). f Body weight gain of
Crtc1−/− and WT females (repeated measures two-way ANOVA: genotype: F(1,24) = 10.527, P = 0.034; weeks: F(3.185,76.443) = 263.167, P < 0.001;
genotype × weeks: F(3.185,76.443) = 0.508; P = 0.689). *P < 0.05 Bonferroni post hoc test
Table 1 Relative mRNA levels of orexigenic and anorexigenic genes in Crtc1−/− and WT males at 8 and 36 weeks of age
8-week-old male mice 36-week-old male mice
Gene WT Crtc1 mice P value WT Crtc1 mice P value
LepRb 1.000 ± 0.157 1.070 ± 0.187 0.778 1.000 ± 0.119 0.564 ± 0.092 0.014*
Cart 1.000 ± 0.129 0.839 ± 0.127 0.408 1.000 ± 0.169 0.521 ± 0.032 0.029*
Nor1 1.000 ± 0.107 0.554 ± 0.063 0.008* 1.000 ± 0.085 0.382 ± 0.079 <0.001*
AgRP 1.000 ± 0.299 2.851 ± 0.599 0.020* 1.000 ± 0.543 0.732 ± 0.287 0.978
Npy 1.000 ± 0.217 0.918 ± 0.268 0.814 1.000 ± 0.109 1.774 ± 0.216 0.005*
Npy-y1r 1.000 ± 0.210 1.371 ± 0.282 0.297 1.000 ± 0.256 1.031 ± 0.192 0.923
Fto 1.000 ± 0.061 0.767 ± 0.037 0.004* 1.000 ± 0.038 0.844 ± 0.045 0.019*
Glp-r1 1.000 ± 0.172 1.178 ± 0.104 0.388 1.000 ± 0.138 0.722 ± 0.106 0.397
*P < 0.05 shown in bold, Student’s t test
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Npy-y1 (Supplementary Table S1 and Supplementary
Fig. S2). Collectively, these results show that Crtc1−/−
males present perturbed expression of both orexigenic
and anorexigenic genes, whereas the lack of CRTC1 does
not induce major alterations in the homeostatic regula-
tion of food intake in mutant females.
The hyperphagia of Crtc1−/− males does not depend on
increased preference for food rewards
Motivation to consume highly palatable food, which
relies on the integrity of the reward system, is also
essential for a proper feeding behavior. Crtc1 is also
expressed in brain structures belonging to the reward
Fig. 2 a–h ARC gene expression in 8-week-old and 36-week-old WT and Crtc1−/− males a LepRb mRNA levels were comparable in 8-week-old males
(WT: n = 12, Crtc1−/−: n = 7), whereas they were reduced in 36-week-old Crtc1−/− males (WT: n = 8, Crtc1−/−: n = 7, P = 0.0143). b Cart expression was
similar in the two groups at 8 weeks (WT: n = 12, Crtc1−/−: n = 8), whereas at 36 weeks Crtc1−/− males had reduced Cart mRNA compared to WT (WT:
n = 7, Crtc1−/−: n = 8, P = 0.0294). c Nor1 mRNA level was signiﬁcantly reduced in Crtc1 mutant males both at 8 weeks (WT: n = 12, Crtc1−/−: n = 7, P =
0.008) and 36 weeks (WT: n = 7, Crtc1−/−: n = 8, P < 0.001). d AgRP transcription was upregulated in 8-week-old Crtc1 mutant males (WT: n = 7, Crtc1−/−:
n = 8, P = 0.020) but not in 36-week-old Crtc1−/− males (WT: n = 10, Crtc1−/−: n = 12). e Npy mRNA levels increased in 36-week-old Crtc1 mutant mice
(WT: n = 9, Crtc1−/−: n = 13, P = 0.005), but not in 8-week-old mice (WT: n = 12, Crtc1−/−: n = 8). f Npy-y1 expression was not altered in Crtc1 mutant
males at both ages (8 weeks: WT: n = 10, Crtc1−/−: n = 8; 36 weeks: WT: n = 10, Crtc1−/−: n = 10).g Fto mRNA level was lowered both in 8-week-old (WT:
n = 12, Crtc1−/−: n = 8, P = 0.004) and 36-week-old Crtc1 mutant males (WT: n = 8, Crtc1−/−: n = 8, P = 0.019). h Glp-r1 transcript levels were not affected
by the lack of CRTC1 (8 weeks: WT: n = 12, Crtc1−/−: n = 7; 36 weeks: WT: n = 12, Crtc1−/−: n = 10). i–l Preference and conditioned response for 0.2%
saccharine solution. i Both Crtc1−/− (n = 5) and WT males (n = 8) showed strong preference for saccharine in a two-bottle choice test. No difference
was observed between the two genotypes (P = 0.521). j Consumption of saccharine in the operant conditioning paradigm. Crtc1−/− males (n = 8)
collected less saccharine rewards during the acquisition phase, compared to WT (n = 8), although the difference was not statistically different. Similar
motivation for saccharine was observed during the cue-induced reinstatement phase (repeated measures two-way ANOVA: genotype: F(1,14) = 2.780,
P = 0.118; phase: F(2,28) = 103.44, P < 0.001; phase × genotype: F(2,28) = 3.688, P = 0.038). k Crtc1
−/− (n = 9) and WT females (n = 9) showed equal
preference for saccharine in the two-bottle choice test (P = 0.246). l No statistically signiﬁcant difference was found in motivated consumption of
saccharine between Crtc1−/− (n = 12) and WT females (n = 13) neither in the acquisition phase nor in the cue-induced reinstatement phase (repeated
measures two-way ANOVA: genotype: F(1,23) = 0.622, P = 0.438; phase: F(2,46) = 117.39; P < 0.001; phase × genotype: F(2,46) = 3.121; P = 0.054).
#P < 0.05,
Student’s t test. *P < 0.05 Bonferroni post hoc test vs acquisition. §P < 0.05 Bonferroni post hoc test vs. extinction
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system, but so far, no study has established whether the
functionality of this system is compromised in Crtc1−/−
mice. Therefore, we compared Crtc1−/− and WT mice for
saccharine preference in a two-bottle choice test and
assessed their capacity to seek for saccharine reward in an
operant conditioning test.
The two-bottle choice tests revealed that mutant mice
and controls had similar preference for saccharine (Fig. 2i,
k), with a preference ratio for saccharine of 78.7%± 2.5 in
WT and of 81.2%± 2.4 in Crtc1‒/‒ males. As expected,
females of both genotype exhibited a clear-cut preference
for saccharine as well (WT= 88.9%± 1.4, Crtc1‒/‒=
85.4%± 2.5).
Both WT and Crtc1‒/‒ males were then trained for self-
administering saccharine in a ﬁxed ratio 1 schedule until
stable intake, and after a period of extinction, we assessed
their ability to reinstate their saccharine seeking behavior
upon presentation of the light and olfactory cues (Fig. 2j).
A two-way repeated measure ANOVA revealed a sig-
niﬁcant main effect for phase (F(2,28)= 103.44, P< 0.001)
and genotype× phase (F(2,28)= 3.688, P= 0.038), but no
effect for genotype (F(1,14)= 2.780, P= 0.118). Although
Bonferroni post hoc tests did not reveal any signiﬁcant
difference between genotypes, the signiﬁcant interaction
revealed by the ANOVA most likely suggests that mutant
males may display a tendency to collect less rewards than
controls (WT= 70.0± 6.45 versus Crtc1‒/‒= 40.5± 6.27
active nosepokes). As a consequence, despite both groups
of mice exhibited a signiﬁcant reinstatement of previously
extinguished nosepoking behavior (WT= 25.9± 5.68 and
Crtc1‒/‒= 30.0± 7.20 active nosepokes), Crtc1‒/‒ mice
manifested an enhanced reinstatement when expressed in
Fig. 3 Spontaneous locomotor activity of Crtc1 mutant mice. a–c Spontaneous locomotor activity of 9-week-old Crtc1−/− (n = 12) and WT males (n =
12). a Total daily spontaneous locomotor activity of Crtc1−/− males was similar to that of WT (P = 0.162). b Spontaneous activity of Crtc1−/− and WT
males during the dark and light phase. Mutant mice showed slightly reduced activity during the dark phase and increased activity during the light
phase (repeated measures two-way ANOVA: genotype: F(1,22) = 71.175, P < 0.001; phase: F(1,22) = 64.713, P < 0.001; phase × genotype: F(1,22) = 108.43, P
< 0.001). c Crtc1−/− and WT daily activity plotted hour-by-hour (repeated measures two-way ANOVA: genotype: F(1,22) = 21.029; P < 0.001; hours:
F(6.65,146.3) = 44.42; P < 0.001; hours × genotype: F(6.65,146.3) = 7.85; P < 0.001). d–f Spontaneous locomotor activity of 9-week-old Crtc1
−/− (n = 11) and
WT females (n = 9). d Crtc1−/− females showed signiﬁcantly higher daily activity than WT (P = 0.026). e Crtc1−/− females moved slightly more than
control females in the dark phase (repeated measures two-way ANOVA: genotype: F(1,18) = 5.17; P = 0.035; phase: F(1,18) = 344.64; P < 0.001; phase ×
genotype: F(1,18) = 0.56; P = 0.464). f Daily activity of Crtc1
−/− and WT females plotted hour-by-hour (repeated measures two-way ANOVA: genotype:
F(1,18) = 6.017; P = 0.025; hours: F(7.068,127.23) = 58.55; P < 0.001; hours × genotype: F(7.068,127.23) = 1.411; P = 0.206) *P < 0.05, Bonferroni post hoc test.
#P <
0.05, Student’s t test
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function of their baseline intake of saccharine (WT=
36.8%± 6.3 versus Crtc1‒/‒= 71.0%± 12.3, Student’s t
test, P= 0.026), most likely due to a ceiling effect
observed during saccharine consumption. In contrast,
mutant and control females both exhibited similar
acquisition, extinction, and reinstatement of saccharine
seeking behaviors (Fig. 2l), suggesting that, overall, the
lack of CRTC1 most likely does not impair operant
responding for saccharine reward in mice.
Crtc1−/− male mice move more during the light phase of
the cycle
Since reduced energy expenditure could induce body
weight gain, we monitored spontaneous locomotor
activity of Crtc1−/− mice in activity cages along 7 days.
The total daily activity of mutant males (Fig. 3a) was
similar to that of controls (WT= 4613.80± 418.38,
Crtc1‒/‒= 5465.70± 414.35), whereas Crtc1‒/‒ females
(Fig. 3d) exhibited signiﬁcant higher activity as compared
to WT littermates (WT= 5245.10± 389.40, Crtc1‒/‒=
6535.40± 414.35, Student’s t test, P= 0.026). A deeper
analysis of Crtc1‒/‒ mice activity during the light and dark
phase of the light cycle pointed out a strong difference in
males’ and females’ behavior (Fig. 3b, e). Mutant females
behaved like control females in the light phase and moved
a little bit more during the dark phase as shown by
repeated measures two-way ANOVA. (genotype: F(1,18)=
5.17; P= 0.035; phase: F(1,18)= 344.64; P< 0.001; phase×
genotype: F(1,18)= 0.56; P= 0.464). However, Bonferroni
post hoc test did not show any statistical difference
between WT and mutant females in this phase of the
cycle (P= 0.237). Intriguingly, Crtc1‒/‒ males presented
Fig. 4 a Representative actograms of one Crtc1 mutant and WT male and female mouse over 7 days. Dark phase and light phase are indicated by the
black and the white bars, respectively on the top of each actogram. Each line of the actogram shows the activity of 48 h. b–c Motivated wheel-
running of 9-week-old Crtc1−/− (n = 11) and WT males (n = 9): b Total activity in the dark (P = 0.002) and c in the light phase (P = 0.449). d–e
Motivated wheel-running of 9-week-old Crtc1−/− (n = 12) and WT females (n = 13): d Total activity in the dark (P = 0.077) and e in the light phase
(P = 0.087). f–g Food consumption of 30-week-old Crtc1 deﬁcient mice in the dark and light phase of the cycle: f Crtc1−/−males ate signiﬁcantly more
during the light phase (repeated measures two-way ANOVA: genotype: F(1,19) = 10.90; P = 0.0037; phase: F(1,19) = 123.63; P < 0.001; phase × genotype:
F(1,19) = 5.32; P = 0.032). g Crtc1
−/− and control females consumed similar amount of food in both phases (repeated measures two-way ANOVA:
genotype: F(1,18) = 0.278; P = 0.604; phase: F(1,18) = 145.23; P < 0.001; phase × genotype: F(1,18) = 2.95; P = 0.102).
§P < 0.05, Mann–Whitney U test.
*P < 0.05, Bonferroni post hoc test
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opposite behavior moving as much as controls in the dark
phase and signiﬁcantly more in the light phase (Bonfer-
roni post hoc test, P< 0.001).
To better characterize this sustained activity of mutant
males during the resting phase, we plotted the daily
activity on a scale of one-hour intervals (Fig. 3c). Mutant
males, compared to controls, moved more when the light
was switched on and maintained a signiﬁcant higher
activity along all the light phase (repeated measures two-
way ANOVA: genotype: F(1,22)= 21.029; P< 0.001; hours:
F(6.65,146.3)= 44.42; P< 0.001; hours× genotype:
F(6.65,146.3)= 7.85; P< 0.001). In contrast to what was
observed with males, the same hour-by-hour analysis did
not reveal any increase in activity of mutant females
during the resting phase (Fig. 3f). Seven-day-double-
plotted actograms of a representative male and female
mouse of both groups clearly showed that Crtc1‒/‒ males,
but not females, have a perturbed circadian locomotor
activity (Fig. 4a).
To conﬁrm the increased mobility of Crtc1‒/‒ males
during the light period of the cycle we also measured their
voluntary activity in cages equipped with a running wheel
(Fig. 4b–e). According to what was observed in the activity
cages, mutant males ran more during the light phase,
whereas their wheel turns in the dark phase were com-
parable to those of controls. Consistent with their spon-
taneous activity, mutant females (Fig. 4d, e) ran as much
as control females during the light phase. Taken together,
these results show that mutant males, but not females,
move more in the resting phase and have a perturbed
light/dark activity.
Crtc1−/− male mice eat more during the light phase
To verify whether there was a relation between hyper-
phagia and light phase activity of Crtc1‒/‒ males, we
determined the quantity of food eaten at the end of the
dark and the light phase of the daily cycle. 24-hour food
intake of Crtc1‒/‒ males was signiﬁcantly higher than
controls (WT= 4.35± 0.15, Crtc1‒/‒= 5.60± 0.17, P=
0.004, Student’s t test) conﬁrming the overeating behavior
observed during weekly measurements. When we calcu-
lated the quantity of food ingested per phase, we found a
consumption of 3.66 g± 0.14 for Crtc1‒/‒ males and of
3.36 g± 0.13 for WT in the dark phase and of 1.93 g±
0.19 and 1.00 g± 0.14 (Bonferroni post hoc test, P<
0.001) in the light phase, respectively (Fig. 4f). These data
support our hypothesis that the hyperphagia of Crtc1‒/‒
males occurs only during the light phase of the cycle. As
expected, Crtc1‒/‒ females (Fig. 4g), which did not show
overeating along all measures of food intake, ate as much
as their WT littermates in 24-h (WT= 4.44 g± 0.14,
Crtc1‒/‒= 4.28 g± 0.24). Food consumption in the active
phase (WT= 3.49 g± 0.13, Crtc1‒/‒= 3.09 g± 0.12) and
in the resting phase (WT= 0.95 g± 0.11, Crtc1‒/‒.= 1.19
g± 0.17) was similar in both genotypes. In conclusion,
these data suggest that the obesity of Crtc1 mutant males
depends, at least in part, on increased food consumption
during the resting phase.
Discussion
Overall, our work conﬁrms the crucial role played by
CRTC1 in energy balance, previously observed by Altar-
ejos et al.6, and shows that male mice lacking CRTC1 are
hyperphagic and more vulnerable to develop obesity than
mutant females, and this, from the beginning of adult-
hood. Indeed, mutant females exhibited a mild late-onset
obesity without hyperphagia. We also found similar pre-
ference and self-administration responding for saccharine
in both sexes. Finally, we observed an altered circadian
activity in mutant males only.
So far, many neurobiological pathways responsible for
food intake regulation have been identiﬁed in the brain26.
The hypothalamus plays an essential role in controlling
hunger and satiety. Due to the anatomical localization of
the ARC, it is the ﬁrst hypothalamic region that receives
peripheral signals informing the brain about energy
availability. Among these peripheral signals, leptin that is
released by adipocytes, promotes fasting by stimulating
CART/POMC neurons and inhibiting AgRP/NPY neu-
rons through the binding to its receptor (LepRb)27.
However, in obesity the large amount of leptin released by
the adipose tissue leads to ARC neurons leptin insensi-
tivity (also called leptin resistance) and contributes to
food overconsumption. Interestingly, Altarejos et al. have
observed that 36-week-old Crtc1‒/‒ mice are leptin
resistant6. Many mechanisms have been proposed to
explain leptin resistance, and one of them is a weak
expression of the long form of the leptin receptors
(LepRb) in the brain28. Accordingly, we found a sig-
niﬁcant reduction of the transcript levels for LepRb in
overweight Crtc1‒/‒ males, but not in young mutant
males.
Recent studies have also shown that leptin can modulate
the transcription of CREB-dependent genes by directly
facilitating CREB phosphorylation29,30 or by enhancing
CRTC1 nuclear translocation31. Because Cart is a CREB-
regulated gene, we expected to ﬁnd reduced levels of Cart
transcript in both young and old Crtc1‒/‒ males. Sur-
prisingly, only old and obese Crtc1‒/‒ males have lowered
levels of Cart transcript, whereas young mice have not.
Therefore, the deletion of Crtc1 per se does not seem to
affect Cart transcription. Two mechanisms may explain
this observation. First, our mice are constitutive knockout
and the presence of CRTC2 in the ARC might compen-
sate for CRTC1 deﬁciency18. Second, CREB phosphor-
ylation is independent from CRTC1 activity and so, even
in its absence, leptin-induced CREB activation may be
sufﬁcient to allow Cart transcription. Conversely, the
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impairment of leptin signal in old Crtc1‒/‒ males, due to
lowered LepRb expression, would have a more detri-
mental effect on CREB activation leading to reduced Cart
transcription. Together, these results suggest that appro-
priate leptin signaling may be crucial for Cart expression.
Since young Crtc1‒/‒ males, despite unchanged Cart
expression, ate more than their age-matched controls, we
explored the possibility that Crtc1‒/‒ males overeating
would depend on the impaired expression of other CREB-
regulated genes. The neuron-derived orphan receptor 1
(NOR1), also known as NR4A3, is a protein belonging to
the nuclear receptor superfamily of transcription fac-
tors32. The transcription of Nor1 is under the control of
CREB and we already reported lowered Nor1 mRNA
levels in the prefrontal cortex and in the hippocampus of
Crtc1‒/‒ mice8. Recently, a work of Kim et al. has shown
that, in ARC neurons leptin seems to facilitate Nor1
transcription through CREB recruitment and that in turn,
Nor1 would reduce appetite by antagonizing
glucocorticoid-induced AgRP release and inhibiting Npy
transcription33. According to this mechanism, we found
that Crtc1‒/‒ males, compared to their age-matched
controls, have signiﬁcantly lower levels of Nor1 tran-
script. Moreover, this change in Nor1 expression was
associated with a rise of AgRP and Npy mRNA level in
young and old Crtc1‒/‒ males, respectively. Overall, our
ﬁndings suggest that, the overeating of young Crtc1‒/‒
males may be induced by the impaired expression of Nor1
and that the appetite of older Crtc1‒/‒ mice would be
affected by a concurrent reduction of Nor1 and Cart
transcription.
The gene coding for the NPY receptor type 1 (NPY-1R)
is another anorexic CREB-regulated gene34. The com-
parison between Crtc1 mutant males and WT littermates
at 8 and 36 weeks of age did not reveal any alteration in
the expression of this gene indicating that it would not
play a critical role in their hyperphagic behavior.
Fat-mass-related and obesity-related gene (Fto) is an
mRNA demethylase whose enzymatic activity has been
associated with increased body mass index and obesity
vulnerability. Although its physiological functions remain
largely unknown, recent investigations have begun to
unravel the link between this enzyme and energy bal-
ance35. In rodents, it has been found that ARC Fto
expression is lowered during fasting36. Moreover, it seems
that this enzyme would delay CREB dephosphorylation
and would inhibit food intake through the expression of
Npy-1r and Bdnf37. In contrast to these previous works,
we found a lower level of Fto transcript in both young and
old Crtc1‒/‒ males. Therefore, additional studies are
required to understand more in detail the physiological
role of FTO in energy balance regulation, and how
CRTC1 interferes with the transcription of this mRNA
demethylase.
The glucagon-like peptide 1 is a peptide that acts as a
strong feeding suppressor in the hypothalamus upon the
binding with its receptor (GLP-R1)38. The overlapping
distribution of GLP-1R and CRTC1 in the hypothalamus,
led us to investigate whether the lack of CRTC1 could
affect the expression of this receptor, but our ﬁndings
indeed show no alteration of its expression.
Unlike males, Crtc1‒/‒ females do not exhibit any food
overconsumption. Consistent with a normal feeding
behavior, 52-week-old Crtc1‒/‒ females do not show any
modiﬁcation in the gene expression pattern, except for a
signiﬁcant increase in Npy-1r transcript. This sexual
dimorphism was not described in the previous study of
Altarejos et al6. Further investigations are needed to
understand why the lack of Crtc1 impairs males pre-
ferentially, and in particular delineating a putative effect
of sex hormones on the CREB–CRTC1 pathway would be
of the highest relevance. Indeed, Choong et al. established
that the vulnerability to develop obesity in patients
bearing a CRTC1 polymorphism varied between men and
women, suggesting that estrogen levels most likely mod-
ulate the effect of this CRTC1 polymorphism on fat
accumulation22.
Eating is a complex behavior driven by energy need and
food rewarding properties. Whereas the homeostatic
control of food intake depends on the functionality of the
hypothalamic nuclei, the motivation to consume highly
palatable food is governed by the reward system. Neurons
of both systems are intimately interconnected39. In par-
ticular, lateral hypothalamic neurons, which integrate
signals coming from other hypothalamic nuclei, project to
VTA-dopaminergic neurons and regulate reward seeking
behavior through the modulation of dopamine release.
Leptin participates in this modulation by inhibiting
dopamine release and consequently the rewarding prop-
erties of food40. Thus, impaired leptin signaling, as that
observed in case of leptin insensitivity, may facilitate food
overconsumption.
Considering the relevance of non-homeostatic feed-
ing27, the fact that CRTC1 is abundantly expressed in
brain structures belonging to the reward system, and
ﬁnally the leptin resistance showed by Crtc1 mutant mice,
we explored the possibility that their overeating could
arise from impairments in reward appreciation. Note-
worthy, regardless of their genotype and sex, all mice
exhibited a drastic preference for sweetened taste over tap
water, and the ability to acquire a stable saccharine intake
in an operant conditioning paradigm. Furthermore, they
all manifested a strong capacity to associate reward
delivery and reward-paired cues, as attested by the rein-
statement of their previously extinguished nosepoking
behavior upon presentation of the olfactory and light cues.
Because Crtc1‒/‒ males may have earned less rewards
during acquisition of saccharine self-administration, an
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observation in line with a previous report of ours indi-
cating that these mutant mice moved less in response to
moderate stressful environments8, we considered the
possibility that Crtc1‒/‒ males obesity could also depend
on insufﬁcient energy expenditure. To answer this ques-
tion, and avoid confusion due to excessive overweight, we
monitored spontaneous and motivated locomotor activity
in young Crtc1‒/‒ mice. Although Crtc1‒/‒ and WT males
had similar total activity, a more detailed analysis of their
behavior showed a great difference between the dark and
the light phase of the cycle. In fact, mutant males, as
expected moved more during the light phase. Contrast-
ingly, Crtc1‒/‒ females were globally more active than
control females but this extra activity was present only in
the dark phase. Voluntary exercise in running wheels
conﬁrmed that Crtc1‒/‒ males, but not females, run more
than controls in the light phase. Collectively, these results
highlight a different locomotor phenotype in Crtc1‒/‒
females and males and show that these latter exhibit a
perturbed nychtemeral activity.
Because of this observation, we tested the hypothesis
that diurnal activity of Crtc1‒/‒ males could coincide with
increased food seeking and food intake. Therefore, we
measured food intake in the two phases of the light cycle.
Crtc1‒/‒ and WT females consumed similar amount of
food both in the dark and light phase. In contrast, mutant
males showed overeating only during the resting phase.
Altogether, these ﬁndings highlight a perturbation of the
circadian rhythms of feeding and locomotor activities in
Crtc1‒/‒ males, thus suggesting that Crtc1 inactivation
induces a gender-speciﬁc alteration of important func-
tions regulated by the circadian clock network. Interest-
ingly, recent reports have pointed out the participation of
CRTC1 in master clock entrainment41,42. Future investi-
gations should unravel the role of this transcription
coactivator in the regulation of clock genes in the
suprachiasmatic nucleus and other brain regions.
Accumulating evidence indicates that disrupted syn-
chronization of feeding and sleeping time with the master
clock results in dampening of metabolic and endocrine
functions. Concerning obesity, alterations in adipogenesis,
satiety signaling, and energy metabolism have all been
associated with circadian regulation43. Likewise, the lack
of synchrony of the internal clock with the daily light cycle
affect glucocorticoid levels and stress reactivity facilitating
the development of emotional disturbances, namely
depression44. In conclusion, improved knowledge of the
mechanisms through which CRTC1 synchronizes meta-
bolic functions with the light cycle may facilitate our
understanding of the biological processes underlying the
interaction between obesity and depression.
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